P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,415.00
-55.00 (-2.23%)
At close: Dec 5, 2025
15.83%
Market Cap 69.75B
Revenue (ttm) 22.13B
Net Income (ttm) 6.65B
Shares Out 28.88M
EPS (ttm) 230.14
PE Ratio 10.49
Forward PE n/a
Dividend 40.00 (1.62%)
Ex-Dividend Date Dec 29, 2025
Volume 97,811
Average Volume 63,476
Open 2,465.00
Previous Close 2,470.00
Day's Range 2,380.00 - 2,470.00
52-Week Range 1,907.00 - 3,300.00
Beta 0.72
RSI 39.12
Earnings Date Nov 14, 2025

About P&K Skin Research Center

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro clinical tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded i... [Read more]

Industry Commercial Physical and Biological Research
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 347740
Full Company Profile

Financial Performance

In 2024, P&K Skin Research Center's revenue was 17.85 billion, an increase of 20.24% compared to the previous year's 14.84 billion. Earnings were 5.82 billion, an increase of 20.84%.

Financial Statements

News

There is no news available yet.